Business Daily from THE HINDU group of publications Friday, Mar 30, 2007 ePaper |
|
|
|
|
|
|
|
Corporate
-
Announcements Marketing - Strategy Web Extras - Pharmaceuticals Mankind Pharma mulls new wing Our Bureau
New Delhi March 29 Mankind Pharma today announced an investment of Rs 15 crore (2007-2008) to set up a marketing division called `Special Mankind' to sell its over-the-counter (OTC) products. The company hopes to make Rs 40 crore for the year 2007-08 from this new segment alone, and plans to introduce sanitary napkins, medicated dressings, diapers and medicated shampoos to its portfolio by the end of this financial year. Mankind also hopes to launch energy drinks and a range of cosmetics soon. "In India, the OTC market for healthcare products is likely to grow at a healthy rate of 30 per cent. Having established strong growth in the ethical market, diversification into the OTC segment was a natural extension for Mankind Pharma," said Mr R.C. Juneja, MD, Mankind Pharma. The product range would initially comprise Manforce Condoms, Unwanted 72-emergency contraceptives and Unwanted Home pregnancy kit, and will be available in the North Indian markets.
Own Production
The company is also setting up a manufacturing plant for injectibles at Ponta Sahib, Himachal Pradesh, HP with a capacity of 30 million ampoules and 30 million vials. The company hopes to start its own production from there from April this year and save at least 5 per cent of their costs. It is also setting up a R&D facility in the National Capital Region later this year, to cater to exports in the future.
More Stories on :
Announcements |
Strategy |
Pharmaceuticals
Article
E-Mail
::
Comment
::
Syndication
::
Printer Friendly Page
|
Stories in this Section |
|
The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription Group Sites: The Hindu | The Hindu ePaper | Business Line | Business Line ePaper | Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |
Copyright © 2007, The
Hindu Business Line. Republication or redissemination of the contents of
this screen are expressly prohibited without the written consent of
The Hindu Business Line
|